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Abstract
The disruption of protein folding homeostasis in the endoplasmic reticulum (ER) results in an
accumulation of toxic misfolded proteins and activates a network of signaling events
collectively known as the unfolded protein response (UPR). While UPR activation upon ER
stress is well characterized, how other signaling pathways integrate into the ER proteostasis
network is unclear. Here, I sought to investigate how the target of rapamycin complex 1
(TORC1) signaling cascade acts in parallel with the UPR to regulate ER stress sensitivity.
Using S. cerevisiae, I found that TORC1 signaling is attenuated during ER stress and
constitutive activation of TORC1 increases sensitivity to ER stressors such as tunicamycin
and inositol deprivation. This phenotype is independent of the UPR. Transcriptome analysis
revealed that TORC1 hyperactivation results in cell wall remodeling. Conversely,
hyperactive TORC1 sensitizes cells to cell wall stressors, including the antifungal
caspofungin. Elucidating the crosstalk between the UPR, cell wall integrity, and TORC1
signaling may uncover new paradigms through which the response to protein misfolding is
regulated, and thus have crucial implications for the development of novel therapeutics
against pathogenic fungal infections.
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Chapter 1

1

Literature Review

2

1.1 The Role of ER Homeostasis in Human Pathology
A number of environmental and genetic conditions can impair protein-folding fidelity in
the endoplasmic reticulum (ER), leading to a build-up of misfolded proteins within the
organelle– a condition known as ER stress1–3. To restore protein-folding homeostasis, the
cell activates a network of intracellular signaling events known as the unfolded protein
response (UPR)2–4. Chronic ER stress and malfunctions in UPR signaling have emerged
as key contributors to a number of human diseases such as neurodegeneration 5,6, cancer7–
9,

and pathogenic fungal infections10–13; however, what remains unclear is how these

signaling pathways mediate disease progression.
A hallmark of the pathology of neurodegeneration is the accumulation of protein
aggregates and misfolded proteins within neurons and surrounding cells. For example, in
Parkinson’s disease, ubiquitinated protein aggregates of -synuclein form characteristic
Lewy bodies14. Additionally, Alzheimer’s disease is characterized by both extracellular
deposits of the amyloid- protein, as well as intracellular deposits of tau protein15. As a
whole, the common theme between these neurological diseases is that the accumulation
of misfolded proteins disrupts protein-folding homeostasis in the ER. While ER stressdriven neurotoxicity is well established, what remains to be understood are the signaling
pathways and mechanisms that mediate these diseases.
Similarly, the role of ER stress in cancer is well established, but poorly understood16,17.
Tumor cells often grow in unfavourable conditions such as hypoxia, inadequate nutrition,
and oxidative stress – all of which compromise protein folding within the ER16,17. As a
result, sustained activation of UPR signaling and increased expression of downstream
UPR targets are prevalent in a wide array of human tumors including glioblastomas and
carcinomas of the breast, stomach, and liver7–9. Despite the vast amount of evidence
implicating ER stress and UPR activation in cancer, how these processes inhibit or
promote tumor growth, remains to be understood.
Additionally, pathogenic fungi, such as Aspergillus fumigatus – the leading agent of
fungal infections in immunocompromised patients, rely heavily on the secretory pathway
to mediate cell wall integrity and enzyme secretion during infection18. Recent studies
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suggest a direct role for the ER in facilitating essential fungal traits such as biofilm
formation and virulence10,12,18. Furthermore, the inability of pathogenic fungi to cause
disease when their ER stress responses11,18 are impaired suggests that targeting molecules
that disrupt these stress pathways could be useful in developing novel anti-fungal
therapies. Therefore, elucidating the signaling pathways that interact with the UPR under
conditions of ER stress will facilitate our understanding of ER-stress related disease
progression.

1.2 Secretory Pathway Homeostasis
The ER is a membrane-bound organelle responsible for the synthesis, post-translational
modification, folding, and quality control of secretory proteins2,19,20. Secretory protein
translation is initiated by cytosolic ribosomes; however, the emergence of a signal
peptide allows the polypeptide to be recognized by a signal recognition particle (SRP),
which directs the ribosome to the ER21,22. Once the ribosome becomes bound to the ER
membrane, polypeptide synthesis continues, and the polypeptide enters the ER lumen cotranslationally. The environment of the ER lumen is highly specialized for protein
folding; not only does the oxidizing potential support disulphide bond formation, but the
high concentration of chaperone proteins also helps to minimize protein aggregation and
facilitate native structure formation20,23,24. While the processes of protein folding and
maturation are assisted, they are also sensitive to changes in ER homeostasis, such as
altered metabolic states, increases in protein synthesis, and the expression of misfolded
proteins25. Conditions that perturb ER homeostasis generate a state known as ER stress,
which can compromise cell integrity due to the accumulation of misfolded proteins 2,4,26.
Therefore, to ensure protein-folding fidelity, cells have evolved an ER quality control
mechanism, ER-associated degradation (ERAD), that ensures that only properly folded
proteins are trafficked to the Golgi apparatus, and that misfolded proteins are targeted to
the proteasome for degradation27–30. If, however, the accumulation of misfolded proteins
exceeds the capacity of the ER quality control machinery, the cell enters a state of stress
and elicits a network of intracellular signaling and transcriptional events that are
collectively known as the unfolded protein response (UPR)2,4.
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1.3 Endoplasmic Reticulum Stress
Depending on the physiological state of the cell, the flux of polypeptides into the ER can
be highly dynamic. Therefore, to preserve protein-folding fidelity, cells adjust the
protein-folding capacity of the ER to meet cellular demands. However, ER homeostasis
can be perturbed by both physiological and pathological conditions such as nutrient
deprivation, high protein demand, or mutant protein expression – all of which can result
in an accumulation of unfolded or misfolded proteins in the ER lumen, a condition
termed ER stress31–33. Additionally, several chemicals induce ER stress in a cell culture
system, including tunicamycin and dithiothreitol (DTT). Tunicamycin blocks the initial
step of glycoprotein biosynthesis in the ER by inhibiting UDP-GlcNAc-phosphate
transferase34. Therefore, treatment with tunicamycin causes an accumulation of misfolded
glycoproteins in the ER, consequently leading to UPR activation. DTT is a potent
reducing agent that disrupts the formation of disulfide bonds between cysteine residues
and causes unfolded proteins to accumulate in the ER35–37.
Changes in lipid metabolism also activate the UPR, independently of the response caused
by an accumulation of misfolded proteins in the ER 38,39. The observation that the ER
protein folding sensor, Ire1, lacking its luminal misfolded protein-sensing domain, was
activated in yeast deprived of lipid precursors provides direct evidence that lipids activate
ER stress response programs independently of their effects on the misfolded protein
burden in the ER lumen 40,41. Furthermore, in yeast studies, where cells were depleted of
phospholipid building blocks, chaperone protein mobility was significantly increased
compared to ER stress conditions where the accumulation of misfolded proteins in the
ER lumen slowed down chaperone protein mobility38. Taken together, these observations
suggest that altering lipid metabolism activates the UPR independently of unfolded
protein levels, implying that multiple modes of UPR activation may exist.
In particular, the phospholipid building block, inositol, plays an essential role in the
interplay between lipid metabolism and ER stress signaling2,42. Perturbations in inositol
metabolism are associated with the activation of several key stress response pathways
such as the UPR and cell wall integrity (CWI) pathways42–44. In fact, early studies
showing that mutations in the UPR pathway confer inositol auxotrophy, highlight the
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notion that stress response signaling is activated by inositol starvation. The depletion of
inositol triggers the ER stress sensor, Ire1, which induces the transcription of inositol
biosynthetic genes such as INO1, the enzyme that catalyzes the rate limiting step of
inositol synthesis3,45. The regulation of INO1 transcription, itself, is mediated by the
repressor protein, Opi1 (Fig. 1.1). Normally, under conditions of high inositol, Opi1
translocates from the ER to the nucleus, where it represses INO1 transcription42. On the
other hand, low concentrations of inositol prevent Opi1 translocation and thus allow
expression of INO142. While it is unclear how exactly inositol deprivation triggers ER
stress, some studies postulate that it triggers the UPR by either causing changes in the
lipid composition of the ER membrane46 or by impairing membrane trafficking44,47.
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Figure 1.1: The regulation of INO1 transcription is mediated by the repressor
protein, Opi1.
In the absence of inositol, the Opi1 repressor is maintained in the ER by phosphatidic
acid (PA). This allows for the expression of INO1 (left). In the presence of inositol, the
cell does not need to expend cellular energy to synthesize inositol, therefore Opi1
dissociates from PA and translocates to the nucleus, where it prevents INO1 transcription
(right).
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1.4 Unfolded Protein Response
ER stress is the imbalance between the protein folding capacity and the protein folding
load in the ER. The cellular response to this imbalance is the activation of the UPR,
which restores ER homeostasis through three primarily adaptive mechanisms: 1)
attenuation of protein translation to reduce the protein load entering the ER, 2)
transcriptional activation of UPR genes to increase protein folding capacity, and 3)
stimulation of membrane lipid synthesis to expand ER volume2,4,26. If ER stress is
prolonged, and ER homeostasis cannot be re-established, then a fourth mechanism, cell
death, is elicited2,26,48.
In mammals, perturbations in ER homeostasis are sensed and transduced to the cytoplasm
and nucleus via three ER-resident sensors: inositol requiring enzyme 1 (Ire1), activating
transcription factor 6 (ATF6), and pancreatic ER eIF2α kinase (PERK; Fig. 1. 2A)1,4,26,49.
These three sensors share similar structures in that they all harbor luminal,
transmembrane, and cytoplasmic domains. In the absence of ER stress the ER chaperone,
binding immunoglobulin protein (BiP), binds to the luminal domain of the three sensors,
thereby maintaining their inactive states50–52. In response to an accumulation of misfolded
proteins during ER stress, BiP dissociates from the sensors in order to bind misfolded
proteins, and thereby activates and initiates UPR signaling. Of the three sensors, Ire1, is
the most conserved branch of the UPR. Following dissociation from BiP, Ire1
oligomerizes, allowing for transautophosphorylation of adjacent kinase domains, and
stimulation of cytosolic endoribonuclease activity1,4,45,53. Once activated, Ire1 excises an
intron from the mRNA of its only known substrate, X-box binding protein 1 (XBP1),
thereby generating an active transcription factor. The spliced variant of XBP1 then
translocates to the nucleus where it binds to an unfolded protein response element
(UPRE) in the promoter sequence of a number of UPR-target genes, thereby regulating
their expression. Genes that are regulated by XBP1 include those that mediate ER protein
folding, quality control, ERAD, and membrane expansion54,55. In addition to the selective
cleavage of XBP1 mRNA, Ire1 also alleviates ER stress by reducing protein synthesis
through regulated Ire1-dependent decay (RIDD), wherein it degrades a subset of ERlocalized mRNA25. Further examination of proteins that bind UPR promoter elements led
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to the identification of the second protein folding sensor, ATF6. While ATF6 is normally
an ER-resident protein, under conditions of ER stress, it is trafficked to the Golgi
apparatus where it is cleaved into an active transcription factor 56. This transcription factor
then translocates to the nucleus where it increases the expression of ER-resident
molecular chaperones and folding enzymes such as BiP, calreticulin, and protein
disulfide isomerase 57. Finally, the third protein folding sensor, PERK, exerts its function
by phosphorylating a component of the translation initiation complex, eukaryotic
initiation factor 2 (eIF2α). When eiF2α is phosphorylated, it prevents the downstream
formation of the ternary initiation complex eIF2-GTP-tRNAMETi, and thereby leads to
global attenuation of protein translation58–60.
Unlike mammals, the sole ER stress sensor in S. cerevisiae is Ire1; however, it functions
in a manner similar to Ire1 in metazoans in terms of its cytosolic endonuclease
activity2,3,61(Fig 1.2B). Upon induction of ER stress, the BiP homologue, Kar2,
dissociates from the luminal domain of Ire1, allowing it to oligomerize,
transautophosphorylate, and activate its cytosolic RNase activity2–4. Ire1 then splices
HAC1 mRNA to generate a functional variant of the transcript, which upon translation
functions as a transcription factor to upregulate genes involved in ER quality control
machinery, ribosome biogenesis, and ERAD components 2,3. Previous literature has also
suggested a role for Hac1 in mediating membrane expansion and lipid biogenesis 62,63.
Taken together, the yeast model of the UPR provides a simplified but representative
model through which ER stress signaling may be investigated.
Interestingly, unlike S. cerevisiae, Schizosaccharomyces pombe, lack both HAC1/XBP1
orthologs and a UPR-dependent transcriptional program64. Instead, under conditions of
ER stress, S. pombe relies exclusively on two means of Ire1-dependent post
transcriptional regulation: 1) RIDD, and 2) processing of Bip1 mRNA within its
3’UTR64. The processing of Bip1 mRNA stabilizes Bip1 and ensures that it is present at
an increased steady state concentration, without increasing transcription64. As such, S.
pombe corrects the protein folding imbalance by decreasing the protein folding load in
the ER. Given that the RIDD function of Ire1 in S. pombe is conserved in higher
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eukaryotes64, exploring how it impacts yeast tolerance to ER stressors could be useful in
understanding the pathways that mediate protein folding homeostasis.
Although the UPR is well characterized, what remains unclear is how it integrates with
other signaling pathways under conditions of ER stress. Interestingly, a reciprocal
connection has been identified between the cell wall integrity (CWI) and ER stress
pathways65–67.
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Figure 1.2: Representative schematic of the unfolded protein response (UPR).
(A) The mammalian UPR consists of three protein folding sensors: PERK, ATF6, and Ire1.
(B) S. cerevisiae UPR. Ire1 is highly conserved from yeast to mammals.
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1.5 Convergence of the UPR and CWI Pathways
Within an external environment, fungi face numerous environmental stressors such as
low nutrient availability and changes in pH and temperature12,68. As such, the fungal cell
wall acts as the first line of defense, providing a rigid cellular boundary to withstand
internal turgor pressure and extracellular stresses. Proper cell wall architecture requires
three major components: β 1-3-glucan, chitin, and mannoproteins– all of which come
together to form a large macromolecular complex 69,70. In response to environmental
stress, the coordinated synthesis of cell wall components occurs through the cell wall
integrity (CWI) pathway, which plays an essential role in maintaining cell wall
homeostasis12,71,72. While the main components of the CWI pathway are conserved in
most species of fungi, the foundational understanding of the CWI pathway stems from
studies in S. cerevisiae 71,73–78. In S. cerevisiae, under conditions of cell wall stress, the
CWI pathway responds through a signaling cascade that links cell-surface sensors, Wsc1,
Mid2, and Mtl1, to a series of intracellular signaling molecules including the Rho1
GTPase, which binds and activates Pkc1, which in turn activates the MAPK signaling
cascade, including Bck1, Mkk1/2, and Mpk1/Slt273,74,76 (Fig. 1.3). Phosphorylated Slt2
then translocates to the nucleus where it regulates the expression of cell-wall genes
through two distinct pathways: 1) the Rlm1 transcription factor; or 2) the Swi4/6 complex
(Fig.1.3). Slt2 activation of the Rlm1 transcription factor allows for the regulation of a
number of genes involved in cell wall homeostasis including GPI proteins and chitin
synthases79. Similarly, Slt2 activation of the Swi4/6 complex not only allows for the
transcription of cell-wall related genes like β 1-3-glucan synthases Fks1 and Fks2, but
also mediates cell-cycle related genes 80.
Defects in the CWI pathway leads to cell lysis when yeast are exposed to environmental
conditions that impair cell wall stability such as high temperature 81 or disruptions in cell
wall synthesis 82. More specifically, loss of function of any component downstream of
Pkc1 leads to cell lysis at elevated growth temperatures; however, this growth defect is
osmoremedial, with the addition of 1M sorbitol, consistent with a defect in cell wall
biogenesis 83,84. Furthermore, mutants in the CWI pathway are more sensitive to cell wall
antagonists such as Calcofluor white 85,86, Congo red 87, and caffeine 88.
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Interestingly, the CWI pathway and secretory pathway are reciprocally affected under
conditions of environmental stress12,89,90. In this regard, defects in CWI cause increased
sensitivity to ER stress and impairments in secretory pathway homeostasis disrupt cell
wall composition. Surprisingly, deletions in genes involved in the CWI pathway,
particularly BCK1 and SLT2, cause extreme sensitivity to the ER stressors, tunicamycin
and DTT66. This suggests that to compensate for cell wall defects during cell wall stress,
the CWI pathway may upregulate a number of cell wall proteins, thereby increasing the
protein flux through the ER, and contributing to ER stress. Conversely, ER homeostasis
is required for proper cell wall biogenesis and for mediating resistance to the cell walltargeting drug, caspofungin67. Fungal mutants lacking HAC1 or IRE1 exhibit increased
sensitivity to the cell wall antagonists, Calcofluor white and Congo red 91. This suggests
that ER stress may compromise the fidelity of cell wall proteins, impair biogenesis of cell
wall constituents, and consequently activate the CWI pathway. Taken together, the
coordination of a number of pathways may be responsible for mediating sensitivity to
environmental stressors.
It is also important to note that both cell wall biogenesis and protein folding in the ER are
highly energetically demanding processes and, as such, low nutrient status is a potent
trigger of the UPR40. Thus, the interconnection between metabolic regulation and the
UPR is a crucial area of study, one that has thus far been inadequately addressed.
Accumulating evidence suggests that the cellular metabolism mediating AMPK signaling
cascade and its subsequent regulation of crucial proteins acetyl-CoA carboxylase and
mTOR, may cooperate with the UPR to mediate cell viability under conditions of ER
stress40,42,49; however, the mechanisms behind this crosstalk remain to be elucidated.
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Figure 1.3: Representative schematic of the cell wall integrity (CWI) pathway in
S. cerevisiae
In yeast cells, the CWI signaling cascade mediates the transcription of cell wall genes by
transducing signals from outer membrane sensors to intracellular effector proteins.
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1.6 ER homeostasis and TORC1 Signaling
The target of rapamycin (TOR) is an evolutionarily conserved serine/threonine kinase
that functions at the core of signaling networks involved in cell growth, metabolism, and
nutrient and hormone sensing92,93. These signaling networks mediate anabolism and
catabolism by coordinating a number of cellular and metabolic processes such as
transcription, protein translation, ribosome biogenesis, and cellular architecture94–97.
TOR kinase genes were originally identified by mutations that conferred resistance to the
growth inhibitory properties of the drug, rapamycin, in budding yeast, Saccharomyces
cerevisiae 92. Unlike yeast which possess two TOR genes (TOR1 and TOR2), higher
eukaryotes contain only one TOR gene (mTOR). Nevertheless, the functional domains
within these proteins are highly conserved (Fig. 1.4A). TOR genes encode relatively large
(~280kDa) proteins that have a conserved C-terminal phosphatidylinositol kinase (PIK)
homology domain, an FKBP12-rapamycin binding (FRB) domain, about 20 tandemly
repeated HEAT motifs to mediate protein-protein interactions, and FAT and FATC
domains which serve as important protein-protein regulators and catalytic activity
mediators, respectively97,98. In all eukaryotes, these TOR kinases are the central
component of two distinct complexes: TOR complex 1 (TORC1) and TOR complex 2
(TORC2), of which only TORC1 is rapamycin sensitive95.
In particular, TORC1 in yeast has a size of ~2MDa and consists of four main proteins:
Kog1, Lst8, Tco89 and either TOR1 or TOR2 (Fig. 1.4B)99,100. Localization studies
demonstrate that TORC1 is localized to the yeast vacuole and that changes in localization
are not necessary for TORC1 signaling 101,102. A major breakthrough in the field came
from the discovery that rapamycin treatment alters cell physiology in a manner similar to
nutrient starvation, such that treatment with rapamycin resulted in a decrease in protein
synthesis, induction of apoptosis, and entrance into a quiescent G0 state92. This
observation was the first indication that TORC1 plays an important role in mediating cell
growth in response to cell nutrient status. In general, TORC1 is responsible for promoting
ribosome biogenesis, cell proliferation, and protein anabolism. In addition to mediating
anabolic processes, TORC1 also promotes cell growth by inhibiting a number of stress
response pathways94,103,104. To date, the best characterized substrate of TORC1 in yeast is
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Sch9, the yeast homolog for the AGC kinase, S6K, and monitoring the phosphorylation
status of this protein is an indicator of TORC1 activity101. Additionally, the
phosphorylation of RPS6, a downstream target of Sch9, is regulated in a TORC1dependent manner and serves as a valid readout for TORC1 activity in vivo105,106. Recent
reports indicate that under conditions of cell stress, Sch9 and RPS6 phosphorylation is
dramatically reduced; however, it is unclear how these stress signals are transduced to
TORC1103,105,106.
Interestingly cells treated with rapamycin activate the CWI pathway, suggesting that the
TORC1 signaling pathway not only impinges upon the CWI pathway, but also negatively
regulates the pathway107,108. Therefore, while initially thought to be distinct pathways,
recent research points to a functional interaction between the UPR, TORC1, and CWI
signaling pathways104,107–109. Nevertheless, the manner in which the CWI, UPR, and TOR
signaling pathways interact remains to be elucidated. Given that these signaling pathways
are all essential for facilitating fungal pathogenesis, understanding the manner in which
these pathways act in parallel to mediate ER homeostasis may allow us to uncover novel
targets for antifungal drugs.
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Figure 1.4: Representative schematic of the TOR1 Kinase and TORC1 complex.
A) Conserved structure of TOR kinases. The functional domains of TOR include tandem
HEAT repeats, the FAT domain, the FRB-rapamycin binding domain, the PIK
homologous kinase domain, and the FATC domain. B) Representative schematic of the
TORC1 complex. The central component of the complex is the TOR1 kinase.

21

1.7 Cellular Pathways mediating Pathogenic Fungal
Infections
The prevalence of pathogenic fungal infections, coupled with the emergence of new
fungal pathogens, has rapidly brought these diseases to the forefront of global health
problems 13. Nearly 2 billion people are afflicted by fungal infections worldwide,
resulting in 1.5 million deaths annually 110,111. While most individuals will suffer from
generally treatable superficial fungal infections, of particular concern are the millions of
people worldwide that will contract life-threating invasive infections – diseases with a
mortality rate which exceeds 50%, even with the availability of antifungal treatments
111,112.

Despite the wide-spread prevalence of these diseases, the study of fungal

infections is greatly lacking when compared to other infectious diseases. As such, there is
a pressing need for research in this field to explore the cellular pathways mediating
infection in order to facilitate the development of novel therapeutics.
The most widespread group of superficial mycoses are fungal infections of the skin and
nails, affecting nearly 25% of the world’s population 112. These infections are primarily
caused by the fungal agents, dermatophytes, and give rise to conditions such as athlete’s
foot, ringworm of the scalp, and infection of the nails 112. Other superficial fungal
infections include mucosal infections of the oral and genital tract, such as oropharyngealor vulvovaginal candidiasis respectively, commonly known as thrush113,114. The vast
majority of these superficial mucosal infections are caused by several species of Candida,
the second most prevalent fungal species worldwide 113–115. Individuals who are
particularly susceptible to mucosal fungal infections include transplant patients,
individuals diagnosed with leukemia, and patients who have undergone radiotherapy111.
While superficial fungal infections are relatively well managed with antifungals,
recurrent infections show decreased sensitivity to antifungal compounds 110,114 and bring
forth the problem of fungal resistance.
While the incidence of invasive fungal infections (IFI) is significantly lower than that of
superficial fungal infections, IFI pose a much greater threat because of their high
mortality rates111,116. The large majority of deaths caused by invasive fungi are often
attributed to opportunistic infections, such that fungal pathogens take advantage of hosts
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with a compromised immune system. As such, patients with the greatest risk of
contracting these life-threatening infections include those diagnosed with
immunosuppressive diseases such as asthma and HIV/AIDs 117–119 or those treated with
immunosuppressive medical interventions such as chemotherapy and radiation 120. As a
whole, the aetiological agents responsible for more than 90% of IFI-related deaths fall
largely within four genera of fungi: Cryptococcus, Candida, Aspergillus, and
Pneumocytis 111,121. While antifungal treatments have advanced over the last decade,
patient outcomes have not substantially improved 122. These shortcomings are largely
attributed to the evolutionary similarity between fungi and humans, which limits the
scope of drug development against fungal specific targets. As such, there is a pressing
need to understand the unique cellular mechanisms that govern fungal viability.
Since the cell wall is essential for fungal survival and its composition is unique to the
fungal organism, this structure acts as an ideal target for antifungal drugs 123. Notably,
echinocandins represent the first class of antifungal drugs that specifically target the
fungal cell wall124,125. In particular, the echinocandin caspofungin acts as a fungicide by
noncompetitively inhibiting the β 1-3-glucan synthases, Fks1 and Fks2, thereby blocking
cell wall synthesis126. Genome-wide microarray analysis of yeast cells treated with
caspofungin revealed that treatment with this drug rapidly and specifically triggers
induction of CWI related genes70. This observation was confirmed by Northern blot
analysis, which demonstrated that caspofungin induced Slt2 phosphorylation 70.
Moreover, cells with deletions in crucial CWI genes, Slt2, Bck1, Pkc1, and Fks1/2, were
all hypersensitive to caspofungin, suggesting that integrity of CWI pathway is required
for tolerance to caspofungin70. Notably, caspofungin also induced the expression of the
chitin synthase, Chs1p70. This is in line with previous studies, which reported that cells
lacking Fks1/2 have a compensatory mechanism induced, resulting in higher chitin and
mannoprotein content 127–129. Given the dual regulation of Fks1/2 by the calcineurin
pathway128,130 (Fig. 1.5), it was also interesting to note that caspofungin caused repression
of the calcineurin gene, CNA1 70,131. Furthermore, pathogenic fungi rely heavily on the
secretory pathway to govern tolerance to antifungal drugs 132,133, mediate cell wall
homeostasis134,135, and express virulence136. Therefore, exploring the connection between
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the CWI pathway, UPR, and nutrient sensing TOR pathway, is integral for understanding
the pathways that mediate fungal pathogenesis.
Given that S. cerevisiae is evolutionarily related to a number of pathogenic fungi, and in
particular to the Candida species137, most genes from S. cerevisiae are highly conserved
in pathogenic fungal strains. This conserved homology makes S. cerevisiae an ideal
model system to identify signal transduction and metabolic pathways required for fungal
survival in the host environment. Among the shared genomic features includes similar
mechanisms for cell wall homeostasis138–140 and activation of stress responses141.
Therefore, S. cerevisiae is a powerful tool to analyze the integration of cellular pathways
that mediate fungal viability.
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Figure 1.5: Ca2+/Calcineurin signaling and CWI converge to mediate FKS2 gene
expression.
The calcium/calcineurin signaling pathway and the CWI pathway dually regulate
expression of FKS2 gene expression under conditions of cell wall or high calcium stress.
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1.8 Hypothesis
My central hypothesis is that attenuation of TORC1 signaling during ER stress is
required for β 1-3 glucan synthase expression and adaptation to proteotoxic stress.
Overall, the goal of this research is to better understand the cross-talk between the TOR
signaling pathway, cell wall integrity pathways, and the UPR, and how the interplay
between these pathways mediates ER stress sensitivity (Fig. 1.6).
Both TORC192 and UPR3,142 signaling were initially characterized in yeast and are
conserved in higher eukaryotes. Therefore, I rationalized that employing the model
organism, Saccharomyces cerevisiae, would be a powerful tool to investigate the
interplay between the UPR and other signaling networks. Among the advantages of
employing yeast is that it is a genetically and biochemically tractable model organism
that allows for rapid and extensive genetic manipulation. Taken together, yeast will
provide an excellent platform to analyze the integration of cellular pathways during ER
stress.

1.9 Objectives
To study my hypothesis, I have three main objectives:
Objective 1: Determine the effect of TORC1 signaling on ER stress sensitivity
Objective 2: Examine how hyperactivation of TORC1 signaling sensitizes cells to ER
stressors
Objective 3: Determine the role of TORC1 signaling in mediating cell wall integrity
during ER stress
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Figure 1.6: TORC1 signaling during ER stress.
It is unclear how TORC1 signaling acts in parallel with the UPR to mediate ER stress
sensitivity. We seek to investigate whether TORC1 signaling has a role in mediating cell
wall architecture, ribosomal biogenesis, and UPR integrity during ER stress.
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2.1 Introduction
The ability of cells to respond to detrimental stresses, such as an aberrant accumulation of
toxic misfolded proteins, dictates cell fate under both normal and pathological conditions.
Loss of secretory protein homeostasis due to pharmacological, genetic, or environmental
perturbations activates a plethora of adaptive responses to help cells overcome the stress
1,2.

In yeast, the ER resident protein Ire1 detects changes in the ER misfolded protein and

activates a transcriptional response termed the unfolded protein response (UPR; 3–7. Upon
induction of ER stress, the ER chaperone, Kar2, dissociates from the luminal domain of
Ire1, allowing it to oligomerize, trans-autophosphorylate, and subsequently activate its
cytosolic RNase activity 4,5,8–10. Ire1 then splices HAC1 mRNA to generate a functional
variant of the transcript, which upon translation functions as a transcription factor to
upregulate genes involved in ER quality control machinery and ribosome biogenesis 5,8.
Cellular adaptation to ER stress is not only dependent on the amplitude of the UPR
signal, but also on the selective expression of UPR target genes capable of overcoming a
particular stress condition 11. Interestingly, Pincus et al. (2014) show that S. cerevisiae
amplify the UPR with time delayed Ras/PKA signaling, indicating that the response to
ER stress is not limited to the UPR 12. Moreover, induction of ER stress activates
transcription of genes associated with other types of stress responses 2. Therefore,
elucidating how the UPR integrates with other signaling pathways under conditions of
ER stress is essential to understand how proteostasis is mediated in the cell.
Given that protein folding in the ER is a highly energetically demanding process, low
nutrient status is a potent trigger of the UPR 13. Therefore, the interconnection between
metabolic regulation and the UPR is a crucial area of study, one that has thus far been
inadequately addressed. Accumulating evidence suggests that the cellular metabolism
mediating AMPK signaling cascade and its subsequent regulation of crucial proteins
acetyl-CoA carboxylase and TOR, may cooperate with the UPR to mediate cell viability
under conditions of ER stress 13–15; however, the mechanisms behind this crosstalk
remain to be elucidated. In yeast, TORC1 inhibition with rapamycin protects yeast cells
from ER stress-induced vacuolar fragmentation and promotes antifungal synergism 16. In
addition, pharmacological induction of ER stress triggers autophagy, a process negatively
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regulated by TORC1 17. It therefore appears that TOR signaling is an important
determinant of the yeast ER stress response.
In S. cerevisiae, TOR kinases are evolutionarily conserved serine/threonine kinases that
function at the core of signaling networks involved in cell growth, metabolism, and
nutrient and hormone sensing 18,19. These TOR kinases are the central component of two
distinct complexes: TOR complex 1 (TORC1) and TOR complex 2 (TORC2), of which
only TORC1 is rapamycin sensitive 20. In particular, the TORC1 signaling network
mediates anabolism and catabolism by coordinating cellular and metabolic processes
such as transcription, protein translation, ribosome biogenesis, and cellular architecture
20–23

. In addition to mediating anabolic processes, TORC1 promotes cell growth by

inhibiting a number of stress response pathways 21,24,25. Nevertheless, the manner in
which the secretory and TORC1 signaling pathway act in parallel, under conditions of ER
stress, remains to be elucidated.
To study the effect of TORC1 signaling on protein folding homeostasis, we employed a
hyperactive variant of the TOR1 kinase (TOR1L2134M ) 15 and assessed yeast sensitivity to
ER stress. We elucidate a novel interplay between proteostasis and TORC1 signaling and
show that attenuation of TORC1 signaling is required for adaptation to ER stress. On the
other hand, constitutive activation of TORC1 confers increased sensitivity to ER
stressors, including the antifungal caspofungin, by compromising cell wall architecture.
Our study, therefore, expands the role of ER homeostasis beyond the UPR and defines
how TORC1 signaling contributes to the ER stress response.

2.2 Materials and Methods
2.2.1

Yeast Strains and Methods

The Saccharomyces cerevisiae strains and plasmids used in this study are listed in Tables
2.1 and 2.2, respectively. All yeast strains are derivatives of BY4742. The TS161 (TOR1)
and TS184 (TOR1L2134M) strains were kind gifts from Dr. Maeda24. BY4742 or
derivatives were thawed from frozen stocks and grown on YPD (yeast extract peptone
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dextrose) or selective SC (synthetic complete) media for 2 days at 30C before being
transferred to liquid cultures. All experiments were carried out using either SC media
containing 2% wv-1 glucose supplemented with 100x inositol or YPD media. Cultures
were grown at 30C with constant agitation or on selective agar plates.
Table 2.1: Yeast Strains
Strains
BY4742

Genotype
MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0

Reference
26, 27

TS161 Wild-type TOR
TS184 Mutant TOR
BY4742 ire1Δ

MATα ura3-52
MATα ura3-52 TOR1L2134M
MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
IRE1::KAN

24
24
Deletion
collection

Table 2.2: Plasmids
Plasmids
pPM47 (UPR-RFP
CEN/ARS URA3)
pAMS366 (4X
CDRE-lacZ
URA3)
pRS316 BCK1-20
pRS416 GPD

2.2.2

Number
Vector Backbone Resistance
Addgene
pRS316
URA
plasmid # 20132
_
pAMS366
URA

Reference
28

–
ATCC 87360

30
31

pRS316
pRS416

URA
URA

29

Spotting and Liquid Growth Assays

Cell growth was assessed by both spot assay and liquid culture as previously described by
Duennwald (2013). Briefly, spotting assays were performed with yeast cells that were
cultured overnight in selective media with 2% glucose as the sole carbon source. Cells
were then diluted to equivalent concentrations of OD 600 0.2 and were spotted in 4
sequential five-fold dilutions. Equal spotting was controlled by simultaneously spotting
cells using a multi-channel ultra-high-performance pipette (VWR International). Cells
were grown on selective plates at 30C for 2 days and imaged using a Geldoc system
(Bio-RAD). For liquid cultures cells were diluted to OD 600 0.15 and incubated at 30C.
OD600 was measured every 15 mins using a BioscreenC plate reader (Growth curves
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USA) for 24 h. Growth curves were generated and the area under the curve was
calculated for biological replicates. Statistical significance was determined using a twotailed student T-test and GraphPad (Prism).

2.2.3

Yeast Transformation

Yeast transformations were performed using the lithium acetate transformation protocol
as previously described32. Briefly, 1 mL of OD600 = 1, overnight cultures were pelleted at
3000 xg for 1 min. Cells were aspirated and washed with 1.5 mL sterile 0.1 M LiAc in
TE buffer. Cells were then pelleted and resuspended in 285 L sterile 50% PEG 4000 in
0.1M LiAc, 2.5 L plasmid, and 10 L boiled salmon sperm DNA, and incubated at
30C for 45 mins. After that, 43 L of sterile DMSO was added and cells were heat
shocked for 15 min at 42C before being plated on amino acid selection plates.

2.2.4

Drugs

Stock solutions of tunicamycin (5 g mL-1 in DMSO; Amresco), calcofluor white (30 mg
mL-1 in H2O; Sigma Aldrich), rapamycin (1 mg ml-1 in DMSO; Fisher Bioreagents),
sorbitol (3 M in H2O; Fisher Bioreagents), and fluorescent brightener 28 (Calcofluor
white stain; 25M; Sigma Aldrich) were used at the indicated concentrations.

2.2.5

Stress Condition Experiments

In all the experiments, yeast cultures were grown to log phase (OD600 ~0.3) before being
exposed to different stress conditions. Endoplasmic reticulum stress was achieved by
adding 0.5 g mL-1, 1.0 g mL-1, or 2.5 g mL-1 tunicamycin (Amresco) or by inositol
withdrawal. For inositol depletion experiments, cells were washed twice in SC media
(YNB-Inositol; Sunrise Science) and then resuspended into pre-warmed SC media
lacking inositol. Cell wall stress was achieved by adding 5-20 g mL-1 calcofluor white.
Sorbitol rescue assays were facilitated by adding 1 M sorbitol to the media.

2.2.6

Quantitative RT-PCR

RNA extraction was performed using the MasterPure Yeast RNA Purification Kit
(Epicentre). cDNA was synthesized using the RevertAid H Minus First Strand cDNA
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Synthesis Kit (Thermoscientific). The cDNA preparations were used as templates for
amplification using SsoAdvancedTm Universal SYBR ® Green Supermix (Bio-Rad). The
primers used are listed in Table 2.3. The relative expression levels were calculated using
the comparative Ct method with U3 as a reference gene.
Table 2.3: Primers
Gene
U3
KAR2
RPL30
INO1
HAC1
PRM5
FKS2
FKS1
FIT1
FIT2
FIT3

2.2.7

Forward Primer
CCCAGAGTGAGAAACCGAAA
CCGGTGAAGAAGGTGTCGAA
ATCATTGCCGCTAACACTCC
TCGACGTACAAGGACAACGA
ACGACGCTTTTGTTGCTTCT
GACATAAGGAAACCCGCAAA
CTGAGCGCCGTATTTCATTT
TTTGGTTCCAATTGGGTGTT
GTGAACGTGCTCCTGTCTCA
GACACCGCTGACCCTATCAT
TATCACTGCCACCAAGAACG

Reverse Primer
AGGATGGGTCAAGATCATCG
CATGGCTCTTTCACCCTCGT
CCGACAGCAGTACCCAATTC
GGCCACTAAAGTGGAGCCAT
TCTTCGGTTGAAGTAGCACAC
CCAGCATGTGCTCGAGATAA
CGGGTGTAATTGCTTCAGGT
CCGCAAACACTTCGAACATA
GTTCACCCTCACCAGTCCAT
GATGATTCGACGGCTTGAGT
AATTCAGCGGTGCTAGAGGA

Fluorescence Microscopy

TOR1 and TOR1L2134M cells expressing a UPR-mcherry fluorescent reporter were grown
to mid-log phase before being treated with 2.5 g mL-1 tunicamycin (Amresco) or
inositol withdrawal for 3 h. Cells were diluted 10X, transferred to a 96 well plate, and
imaged at room temperature. Fluorescence microscopy was performed using the
Cytation 5 Cell Imaging Multi-Mode Reader (BioTek); the 20X objective lens and Texas
Red Filter cube (586 647-1 nm) were used. Images were analyzed using ImageJ software
(https://imagej.nih.gov/ij/). Violin plots presented in Figure 2.2D were generated using
the PlotsOfData software 33.

2.2.8

HAC1 Splicing Assay

Cells were cultured to mid-log phase before being treated with either 1.0 g/mL
tunicamycin (Amresco) or inositol withdrawal for 2 h. RNA extraction was performed
using the MasterPure Yeast RNA Purification Kit (Epicentre). cDNA was synthesized
from the extracted RNA using the RevertAid H Minus First Strand cDNA Synthesis Kit
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(Thermoscientific). The cDNA preparations were then used as templates for RT-PCR
with HAC1 primers (listed in Table 4). The resulting reaction product was separated by
electrophoresis on an agarose gel and bands were visualized using a Geldoc system (BioRad).

2.2.9

β-galactosidase Assay

TOR1 and TOR1L2134M yeast strains transformed with plasmids carrying the CDRE-LacZ
reporter were assayed as previously described 34. Briefly, cells were grown to log phase
in selective SC media, harvested by centrifugation, then cultured in SC media containing
the indicated concentrations of stressors or CaCl2. After incubation at 30C for 2 h, cells
were harvested by centrifugation and resuspended in lacZ buffer. To measure βgalactosidase activity, 50 L cell lysate was mixed with 950 L lacZ buffer containing
2.7 L β-mercaptoethanol, 1 drop 0.1% SDS, 2 drops CHCl3 and incubated at 30C for
15 min. The reaction was started by adding 100 L ONPG (4 mg mL-1) and incubated at
30C till the colour changed to yellow. The reaction was stopped by adding 300 L of 1
M Na2CO3. β-galactosidase activity was determined at 420 nm absorbance using a plate
reader, normalizing data to cell density.

2.2.10

Protein Extraction and Western Blot

Cells were lysed using alkaline lysis with 0.1 M NaOH 35 and proteins were extracted
into 4x Laemmli sample buffer containing 100 mM DTT. Protein samples were separated
using SDS-PAGE (BioRad Mini-PROTEAN TGX Pre-Cast gels, 4-15%) and transferred
to nitrocellulose membranes using the BioRad Trans-Blot® TurboTM RTA Transfer Kit.
Membranes were blocked with 5% fat free milk for 30 mins, before probing with P-S6
Ribosomal Protein S235 236-1 Rabbit Ab (Cell Signaling Technology) or anti-PGK1
(Invitrogen) overnight at 4C. Membranes were then incubated with the Alexa Fluor 488
goat anti-rabbit for 1 hr. Membranes were imaged using a BioRad infrared imager
(BioRad).
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2.2.11

Calcofluor White Stain Microscopy and Flow Cytometry

TOR1 and TOR1L2134M cells were grown in triplicate to mid-log phase in YPD media,
before being treated with Fluorescent Brightener 28 (Sigma-Adlrich) to a final
concentration of 25 M. Cells were grown for 20 min at 30C with continuous shaking
before they were pelleted and washed in SC media. Cells were diluted 10x in growth
media and plated in Lab-Tek (Thermo Inc.) imaging chambers and processed for
fluorescence microscopy. Images were acquired using a Zeiss AxioVert A1 wide filed
fluorescence microscopy equipped with a 63X NA 1.4 Plan Apopchromat objective, 359
nm excitation 461 nm-1 emission (DAPI) long pass filter and an AxioCam ICm1 R1 CCD
camera (Carl Zeiss inc.). Images were analyzed using ImageJ software. For flow
cytometric analysis, cells were cultured in appropriate media and processed for flow
cytometry using a BD Bioscience FACS Celesta flow cytometer equipped with a 405 nm
Violet laser. Data was analyzed using the BD FACS Diva Software. All conditions were
performed in triplicate, 20 000 cells were analyzed, and mean fluorescence intensities
were calculated. No gates were applied.

2.2.12

Microarray Analysis

TOR1 and TOR1L2134M yeast cultures were grown to log phase (OD600 ~0.3) before being
treated with tunicamycin (2.5 μg/mL). RNA was extracted from two independent cultures
(n=2) and quality was assessed with Bioanalyzer as previously described 36. Microarray
analysis was conducted with the GeneChip® Yeast Genome 2.0 Array (Affymetrix, Santa
Clara, California, USA). Briefly, biotinylated complimentary RNA (cRNA) was prepared
from 100 ng of total RNA as per the GeneChip 3’ IVT PLUS Reagent Kit manual
(ThermoFisher Scientific, Waltham, MA). Data was analyzed using the Transcriptome
Analysis Console (TAC) software (Affymetrix) by filtering for genes that showed a twofold change in expression with a p-value of 0.05 using sacCer3 as a reference genome.
Gene lists were created using the gene ontology term finder on the Saccharomyces
genome database (https://www.yeastgenome.org/). All microarray data were submitted to
the GEO database as series GSE129200.
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2.3 Results and Discussion
2.3.1

Hyperactive TOR1L2134M sensitizes cells to ER stress

Previous studies show that the TOR pathway links nutrient status to cell growth and
ribosome biogenesis, under conditions of protein misfolding stress 37–39. However, it
remains unclear to what extent modulation of TORC1 signaling is required for adaptation
to ER stress. Thus, we sought to investigate the effects of TORC1 signaling on the
sensitivity to ER stress.
The phosphorylation of the ribosomal protein, RPS6, is regulated in a TORC1-dependent
manner and serves as a valid readout for TORC1 activity in vivo 40,41. Previous reports
indicate that under conditions of oxidative- and proteotoxic stress, RPS6 phosphorylation
is dramatically reduced 42,43. Therefore, we sought to investigate whether ER stress
downregulates RPS6 phosphorylation in cells with hyperactive TORC1 signaling (Fig.
2.1A). As such, cells expressing either WT TOR1 or hyperactive TOR1L2134M were treated
with the canonical ER stress inducer, tunicamycin (Tm; Fig. 2.1B). Tm is a potent
inducer of the UPR as it inhibits N-glycosylation of proteins, prevents proper protein
folding, and thereby causes an accumulation of misfolded proteins in the ER 44. While the
addition of Tm (2.5 ug/mL) significantly decreased RPS6 phosphorylation in cells
expressing WT TOR1, there was no significant difference in cells expressing hyperactive
TOR1L2134M (Fig. 2.1B-C). Rapamycin, an inhibitor of TORC1, was used as a positive
control, for Sch9 downregulation. Combined with previous studies showing that
phosphorylation of Sch9, another TORC1 effector, is decreased during Tm treatment 45,
our results suggest that TORC1 deactivation plays an important role in ER stress
tolerance. As such, we then sought to determine how impacting proper TORC1 signaling
affects the cell’s response to ER stressors.
First, we assessed cell growth in the presence of both Tm and the TORC1 inhibitor,
rapamycin (Fig. 2.1D). We found that rapamycin treatment exacerbates the growth defect
caused by Tm-induced ER stress (Fig. 2.1D). Similarly, cells expressing a rapamycinresistant hyperactive TOR1L2134M 24 displayed an increased growth defect upon Tm stress
(Fig. 2.1D). To investigate the effects of hyperactive TOR1 on a more physiologically
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relevant ER stressor, cells were exposed to conditions of inositol withdrawal. While it is
unclear how exactly inositol deprivation triggers UPR activation, some studies have
postulated that it triggers the UPR by either changing the lipid composition of the ER
membrane 46–48 or by impairing membrane trafficking 49,50. In contrast to cells expressing
WT TOR1, cells expressing the hyperactive allele were inositol auxotrophs (Fig. 2.1D).
Increased ER stress sensitivity of TOR1L2134M was confirmed using liquid growth assays
(Fig. 2,1E-F). As expected, compared to cells expressing WT TOR1, cells expressing
hyperactive TOR1L2134M had a significant growth defect following treatment with Tm
(Fig. 1E) or inositol withdrawal (Fig. 2.1F). Taken together, our results indicate that
defective TORC1 signaling increases sensitivity to canonical ER stressors. Both
phenotypes can be linked to a defective response to ER stress.
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Figure 2.1: Cells expressing hyperactive TOR1L2134M are more sensitive to ER stress
(A) Representative schematic of the downstream targets of TORC1 kinase activity. (B)
Western blot analysis of RPS6 phosphorylation following treatment with tunicamycin
(Tm; 2.5 μg/mL) or rapamycin (Rap; 200 ng/mL). Pgk1 was used as a loading control.
(C) Quantification of (B). Sch9 phosphorylation is not attenuated in hyperactive
TOR1L2134M cells following treatment with tunicamycin (n=4; ± SD). (D) Cell growth of
WT TOR1 and TOR1L2134M cells was assessed by serial dilutions on YPD plates
supplemented with rapamycin (Rap; 10 ng/mL), tunicamycin (Tm; 1.0 μg/mL), both Rap
and Tm, or SC plates supplemented without inositol (+/- Inositol). Cells expressing
hyperactive TOR1L2134M were more resistant to rapamycin treatment and more sensitive to
tunicamycin stress and inositol withdrawal. (E) Liquid growth assays of yeast cells
expressing WT TOR1 and TOR1L2134M were used to further assess sensitivity to
tunicamycin stress (Tm; 1.0 μg/mL) and (F) inositol withdrawal (-Ino). Data is quantified
as area under the curve (AUC; *p < 0.01; mean ± SD; n=3).
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2.3.2

Cells expressing hyperactive TOR1L2134M have a functional
UPR

Having shown that cells expressing hyperactive TOR1L2134M are more sensitive to ER
stress, we next sought to examine whether this increased sensitivity was due to defects in
the ability to activate the UPR. As previously described, under conditions of ER stress,
the ER protein folding sensor, Ire1, splices HAC1 mRNA to produce an active
transcription factor 4. We therefore assessed the ability of Ire1 to splice HAC1 mRNA
using RT-PCR (Fig. 2.2A-B). Surprisingly, inositol withdrawal induced HAC1 splicing in
both WT TOR1 and hyperactive TOR1L2134M mutants (Fig. 2.2A, arrow). Additionally,
after 1 hr of treatment with Tm, cells expressing hyperactive TOR1L2134M spliced HAC1
mRNA, and this response was still evident after 2 hrs of induction, as indicated by a
smaller fragment in the agarose gel (Fig. 2.2B, arrow). As a whole, these results indicate
that increased ER sensitivity of cells expressing hyperactive TOR1L2134M is not due to
impaired functionality of the UPR.
Spliced HAC1 mRNA is translated into an active transcription factor, which then
translocates to the nucleus where it binds to unfolded protein response element (UPRE)
sequences in gene promoters44. In response to ER stress, Hac1 alone activates over 400
UPR target genes, including ER chaperones, genes that mediate membrane expansion,
and genes involved in ribosome biogenesis 1,51,52. As such, increased sensitivity to ER
stress may be due to an inability to transcriptionally activate the UPR. We tested this
possibility by transforming a UPRE-mcherry fluorescent reporter 28 into cells expressing
TOR1 and TOR1L2134M and assessing UPR activation with fluorescence microscopy (Fig.
2.2C-D). Surprisingly, there was no significant difference between cells expressing TOR1
and hyperactive TOR1L2134M in their ability to activate the UPR under conditions of Tm
stress and inositol withdrawal. Additionally, we quantitatively assessed the mRNA levels
of the yeast resident chaperone and canonical UPR target gene, KAR2, using qRT-PCR
(Fig. 2.3A). In line with our previous data, hyperactive TOR1L2134M was able to increase
the expression of KAR2, following treatment with Tm and inositol withdrawal. Taken
together, these results suggest that the increased sensitivity of cells expressing
TOR1L2134M to ER stress is unlikely to be due to impaired UPR activation.
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Additionally, actively dividing yeast allocate up to 85% of their transcriptional activity to
ribosome biogenesis 53; however, under conditions of ER stress, there is a downregulation
in the expression of ribosome genes in order to increase the expression of UPR target
genes 54,55. As such, we employed qRT-PCR to assess the expression of RPL30, a gene
involved in ribosome biogenesis (Fig. 2.3B). Cells expressing hyperactive TOR1L2134M
significantly downregulated expression of RPL30 (Fig. 2.3B). This is probably due to the
fact that multiple pathways regulate ribosome biogenesis. For example, PKA deactivation
during ER stress is also responsible for repressing transcription of ribosomal protein
genes 12. Furthermore, depleting inositol triggers the ER sensor, Ire1, which induces
transcription of the inositol biosynthetic gene, INO1 8,56. Therefore, we investigated
whether the inositol auxotrophy of cells expressing TOR1L2134M was due to the inability to
synthesize INO1. Cells expressing TOR1 and TOR1L2134M were treated with inositol
withdrawal and qRT-PCR was conducted to assess the expression of INO1 and RPL30
(Fig. 2.3C-D). Interestingly, hyperactive TOR1L2134M impaired the transcription of INO1
(Fig. 2.3C) but did not impair ribosome biogenesis (Fig. 2.3D). Taken together, these
results suggest that under conditions of ER stress, cells expressing hyperactive
TOR1L2134M are defective in regulating INO1 transcription.
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Figure 2.2: The UPR is not impaired in yeast cells expressing hyperactive
TOR1L2134M
(A) Treatment with ER stressors induces HAC1 mRNA splicing. WT TOR1 and
hyperactive TOR1L2134M mutants were either untreated (Ctrl.), treated with inositol
withdrawal (-Ino), or (B) treated with tunicamycin (Tm; 1.0 μg/mL) for up to 2 hrs. RTPCR was conducted using HAC1 primers. Arrows indicate Ire1 mediated HAC1 splicing.
(C) Representative fluorescence microscopy images of WT TOR1 and TOR1L2134M cells
expressing UPR-mcherry fluorescent reporters, following treatment with tunicamycin
(Tm; 1.0 μg/mL) and inositol withdrawal (-Ino) for 2 hours. (D) Quantification of (C).
Hyperactive TOR1L2134M promotes expression of UPR-induced genes in conditions of
tunicamycin stress and inositol withdrawal (n=50; *p < 0.0001).
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Figure 2.3: Hyperactive TOR1L2134M can transcriptionally activate the UPR, but
has impaired inositol synthesis
(A) Representative fluorescence microscopy images of WT TOR1 and TOR1L2134M cells
expressing UPR-mcherry fluorescent reporters, following treatment with tunicamycin
(Tm; 1.0 μg/mL) for 2 hours. (B) Quantification of (A). Both WT TOR1 and hyperactive
TOR1L2134M have significantly increased UPR-mcherry fluorescence following treatment
with tunicamycin (n=50; *p<0.05). (C) Fluorescence microscopy of WT TOR1 and
TOR1L2134M cells expressing UPR-mcherry fluorescent reporters, following treatment
with inositol withdrawal (- ino). (D) Quantification of (C). Hyperactive TOR1L2134M
promotes expression of UPR-induced genes in conditions of inositol withdrawal (n=50;
*p<0.05).

63

2.3.3

Defects in cell wall integrity underlie TOR1L2134M sensitivity to
ER stress

Despite having a functional UPR, our studies show that cells expressing hyperactive
TOR1L2134M have increased sensitivity to canonical ER stressors. Therefore, to assess how
ER stress alters the transcriptome in hyperactive TOR1L2134M mutants, we treated two
independent cultures of WT TOR1 and hyperactive TOR1L2134M cells with Tm and used
microarray analysis to uncover genes that were differentially expressed in hyperactive
TOR1L2134M cells (Fig. 2.4A-D). Data was analyzed by filtering for genes that showed a
two-fold change in expression with a p value < 0.05. The transcripts of the genes that
were differentially downregulated (Fig. 2.4C) and upregulated (Fig. 2.4D) were
categorized based on their cellular components using the yeast SGD GO term finder.
Interestingly, among the genes that were upregulated, a large majority encoded proteins
that localized to the cell periphery and plasma membrane (Fig. 2.4D). Of note, genes
encoding three cell wall incorporated mannoproteins, FIT1, FIT2, and FIT3 were
upregulated in hyperactive TOR1L2134M cells (Fig. 2.4D). Fit proteins are involved in iron
uptake 57. Validation with qRT-PCR revealed that hyperactive TOR1L2134M cells had
significantly higher steady-state levels of FIT1, FIT2, and FIT3, compared to cells
expressing WT TOR1 (Fig. 2.4E-G). Interestingly, FIT genes are also upregulated in cells
carrying deletions in genes encoding the phosphatases PTC1 and PTC6 that displayed
compromised TORC1 signaling 58. Additionally, the expression of both FIT2 and FIT3
was significantly higher compared to WT TOR1 cells following treatment with Tm (Fig.
2.4F-G). Interestingly, increased mannoprotein levels is observed in cells with
compromised cell wall 59. Taken together, these results suggest that hyperactive
TOR1L2134M alters the cell wall composition of yeast cells.
ER stress tolerance in yeast depends on the activation of the cell wall integrity pathway,
which is, in part, regulated by TORC1 60–64. Additionally, cells with defects in cell wall
integrity exhibit inositol auxotrophy 65. As such, we investigated whether the increased
sensitivity of cells expressing hyperactive TOR1L2134M was due to defects in cell wall
integrity. A general approach to assess whether a specific phenotype is due to a cell wall
defect is to test the remediating effects of the cell wall stabilizer sorbitol 66. Interestingly,
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supplementing with sorbitol rescued the toxicity caused by Tm stress in hyperactive
TOR1L2134M mutants (Fig. 2.5A), suggesting that these cells have a defective cell wall. To
further examine cell wall composition, cells expressing TOR1 and TOR1L2134M were
treated with the cell wall antagonist, calcofluor white (CFW) and liquid growth assays
were assessed (Fig. 2.5B). In line with our previous results, cells expressing hyperactive
TOR1L2134M were significantly more sensitive to CFW than cells expressing WT TOR1
(Fig. 2.5B). Previous literature indicates that due to increased activation of cell wall stress
responses, yeast strains with defects in cell wall integrity have a greater deposition of
chitin in their cell wall and become more sensitive to the CFW 67. Therefore, cells
expressing TOR1 and TOR1L2134M were stained with CFW and chitin staining was
analyzed using fluorescence microscopy and flow cytometry (Fig. 2.5C). Compared to
WT TOR1 cells, cells expressing hyperactive TOR1L2134M appeared more clustered and
displayed significantly more chitin content (Fig. 2.5C). Taken together, our data suggests
that the increased sensitivity of hyperactive TOR1L2134M mutants can be traced back to
defects in cell wall integrity.
Consistent with a defect in cell wall biogenesis, loss of function of any kinase
downstream of the canonical MAPK cell wall integrity pathway (CWI) results in growth
defects at elevated temperatures 68–71. Therefore, we investigated whether the increased
sensitivity of hyperactive TOR1L2134M to ER stress could be attributed to defects in the
canonical CWI pathway. Surprisingly, compared to WT TOR1 cells, cells expressing
hyperactive TOR1L2134M showed no growth defect at elevated temperatures (Fig. 2.5D).
To further investigate whether the CWI pathway was impaired, we assessed the effects of
constitutive activation of the CWI pathway by transforming a hyperactive BCK1-20 allele
into WT TOR1 and hyperactive TOR1L2134M cells (Fig. 2.5E). Interestingly, BCK1-20
overexpression equally rescued Tm toxicity in both WT TOR1 and hyperactive
TOR1L2134M cells (Fig. 2.5E), with TOR1L2134M cells still displaying increased sensitivity
compared to wild-type. These results indicate that other regulators of the cell wall
composition downstream of Bck1 may be defective in the mutant cells.
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Figure 2.4: ER stress induces a change in the cell wall composition of cells
expressing hyperactive TOR1L2134M
(A) Microarray analysis of genes differentially expressed in yeast cells expressing WT

TOR1 or hyperactive TOR1L2134M, following treatment with tunicamycin (Tm; 2.5
μg/mL). Arrows indicate cell wall genes that are differentially expressed in cells
expressing hyperactive TOR1L2134M. (B) Microarray analysis of genes differentially
expressed in TOR1 and TOR1L2134M control cells compared to TOR1 and TOR1L2134M cells
treated with tunicamycin (Tm; 2.5 μg/mL). (C) Genes downregulated two-fold in
hyperactive TOR1L2134M cells in response to tunicamycin stress (Tm; 2.5 μg/mL). (D)
Genes upregulated two-fold in hyperactive TOR1L2134M cells in response to tunicamycin
stress. Gene ontology lists were generated with the gene ontology term finder on the
Saccharomyces genome database. Numerous cell wall genes are differentially expressed
in hyperactive TOR1L2134M cells compared to cells expressing WT TOR1. (E) qRT-PCR
was used to validate the microarray analysis and assess expression of mannoprotein genes
FIT1, (F) FIT2, and (G) FIT3 following treatment with tunicamycin (Tm; 2.5 μg/mL;
n=3; ± SD).
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Figure 2.5: Increased sensitivity of hyperactive TOR1L2134M, in response to ER
stress, is due to defects in cell wall integrity
(A) Cell growth of WT TOR1 and TOR1L2134M cells was assessed by serial dilutions on
YPD plates supplemented with various concentrations of tunicamycin (Tm), sorbitol (1
M), or both tunicamycin and sorbitol. Sorbitol rescues tunicamycin toxicity caused by
hyperactive TOR1L2134M. (B) Liquid growth assay of TOR1 and TOR1L2134M cells
following treatment with calcofluor white (CFW; 20 μg/mL). Data was quantified by
measuring area under the curve (AUC; n=3; *p < 0.001; mean ± SD). C) Representative
fluorescence microscopy images of cells expressing WT TOR1 and hyperactive
TOR1L2134M, following treatment with calcofluor white (CFW; 20 μg/mL). Cells
expressing hyperactive TOR1L2134M are aggregated and have increased fluorescence,
corresponding to an increase in chitin synthesis (Left panel). Flow cytometric analysis of
cells treated with calcofluor white (CFW; 2.5 μg/mL). Cells expressing hyperactive
TOR1L2134M have significantly higher mean fluorescence intensity compared to WT TOR
cells (right panel; n = 3; mean ± SD). (D) Growth of WT TOR1 and TOR1L2134M cells in
response to elevated temperature was assessed by serial dilution on YPD plates. There
was no growth defect caused by hyperactive TOR1L2134M. (E) Cell growth of WT TOR1
and TOR1L2134M transformed with either an empty vector or BCK1-20 was assessed by
serial dilution on SC-ura plates supplemented with various concentrations of tunicamycin
(Tm).
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2.3.4

Hyperactive TOR1L2134M cells have defects in glucan
synthase expression and are more sensitive to the
antifungal, caspofungin

Within the host organism, pathogenic fungi face numerous environmental stressors such
as low nutrient availability and changes in pH and temperature 72,73. As such, the fungal
cell wall acts as the first line of defense, providing a rigid cellular boundary to withstand
internal turgor pressure and extracellular stresses 74. Proper cell wall architecture requires
three major components: β-1-3-glucan, chitin, and mannoproteins– all of which come
together to form a large macromolecular complex 74,75. Our results indicate that cells
expressing hyperactive TOR1L2134M increase expression of mannoprotein genes as well as
chitin aggregation, both of which are phenotypes associated with impaired β-1-3-glucan
synthesis 76–78. To test this possibility, we used qRT-PCR to assess the expression of the
β-1-3-glucan synthase genes, FKS2 and FKS1 (Fig. 2.6A-B). Interestingly, expression of
both FKS2 (Fig. 2.6A) and FKS1 (Fig. 2.6B) was significantly decreased in hyperactive
TOR1L2134M cells, following treatment with Tm. Given that Ca2+/ calcineurin and CWI
signaling converge to mediate FKS1/2 expression 77,79, we differentially assessed the
activity of these pathways. There was no evidence that the Ca2+/ calcineurin pathway was
impaired in presence of Tm-induced ER stress (Fig. 2.7). Additionally, we examined the
activation of Rlm1 – another transcription factor regulating cell wall integrity– by
assessing the expression of its downstream target, PRM5 (Fig. 2.6C). We found that
activation of the Rlm1 branch was not impaired in hyperactive TOR1L2134M cells (Fig.
2.6C). Taken together, our results support the notion that defects in the cell wall
architecture of hyperactive TOR1L2134M mutants may be due to dysregulation of other
regulators of the cell wall integrity such as the SWI4/6-SBF complex. More
comprehensive studies will be required to uncover the complex role of TORC1 in the
control of cell wall biogenesis and maintenance.
Given that the cell wall is essential for fungal survival and its composition is unique to
the fungal organism, this structure acts as an ideal target for antifungal drugs 80. Notably,
echinocandins represent the first class of antifungal drugs that specifically target the
fungal cell wall 81,82. In particular, the echinocandin caspofungin acts as a fungicide by
noncompetitively inhibiting the β-1-3-glucan synthases, Fks1 and Fks2, thereby blocking
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cell wall synthesis 83. Since our results indicate that hyperactive TOR1L2134M impairs
FKS2 and FKS1 synthesis, we investigated whether this defect sensitizes cells to the
antifungal, caspofungin (Fig. 2.6D). Indeed, cells expressing hyperactive TOR1L2134M
exhibited a growth defect as compared to WT TOR1 cells, and this defect was further
exacerbated with increasing concentrations of caspofungin (Fig. 2.6D). To further
elucidate the connection between ER stress signaling and sensitivity to antifungal drugs,
we examined the growth of ire1Δ cells following treatment with caspofungin (Fig. 2.6E).
Compared to wild-type strains, ire1Δ showed hypersensitivity to caspofungin, suggesting
that a functional ER stress response is required for resistance to this antifungal drug (Fig.
2.6E). Similarly, UPR-deficient strains of pathological fungi such as C.
neoformans and A. fumigatus show decreased virulence in animal models 84–87.
Interestingly, deletion of MDS3 in Candida albicans leads to TORC1 hyperactivation
resulting in filamentation defects, supporting a negative role for TORC1 hyperactivation
in pathogenicity 88. Conversely, reduced TORC1 signaling in oma1Δ strains resulted in
attenuated TORC1 signaling and increased virulence in Candida albicans 89. Thus, the
amplitude of TORC1 signaling emerges as an important determinant of the capacity of C.
albicans cells to withstand stress such as oxidative stress 90 and perhaps ER stress, thus
impacting its virulence and pathogenicity.
While initially described as distinct pathways, our research points to a functional
interaction between the UPR, TORC1, and CWI signaling pathways. Here, we use a
hyperactive variant of TOR1 to present a novel mechanism of ER stress regulation by
TORC1 signaling. We show that attenuation of TORC1 signaling is required for
adaptation to ER stress, and that hyperactive TORC1 signaling results in compromised
cell wall architecture. Taken together, we propose that hyperactivation of TORC1
signaling alters cell wall composition, sensitizing cells to ER stress causing agents such
as antifungal drugs.
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Figure 2.6: Cell wall perturbations in hyperactive TOR1L2134M cells can be traced
back to defects in glucan synthase activity
(A) Cells expressing WT TOR1 or hyperactive TOR1L2134M were treated with tunicamycin
(Tm; 2.5 μg/mL) for 2 hrs. Tm induced a significant decrease in the expression of glucan
synthase genes FKS2 and (B) FKS1 as measured by qRT-PCR (n=3; ± SD). (C) qRTPCR was also used to assess the expression of the Rlm1 target, PRM5 (n=3; ± SD). (D)
Cell growth of WT TOR1 and TOR1L2134M cells was assessed by serial dilutions on YPD
plates supplemented with various concentrations of the antifungal drug, caspofungin.
Compared to WT TOR1, hyperactive TOR1L2134M cells have impaired growth. (E) Growth
of wild-type cells and Ire1Δ cells was assessed by serial dilutions on YPD plates
supplemented with various concentrations of the antifungal drug, caspofungin. Ire1Δ
cells have increased sensitivity to caspofungin.
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Figure 2.7: The Ca2+/calcineurin pathway is not impaired in hyperactive
TOR1L2134M cells
(A) β-galactosidase activity (measured in LacZ units) was used to assess expression of
calcineurin dependent response element (CDRE) following treatment with CaCl2 (1 M),
tunicamycin (Tm; 1.0 μg/mL), or inositol withdrawal (-ino; n =6). (B) Growth of cells
expressing WT TOR1 or hyperactive TOR1L2134M was assessed by liquid growth assay
following treatment with 0.05 M CaCl2, (C) 0.08 M CaCl2, (D) 0.1 M CaCl2, or (E) 0. 2
M CaCl2. The area under the curve (AUC) was quantified for each replicate (n=3). There
was no significant difference (p > 0.05) between the two yeast strains.
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2.3.5

Conclusion

The high prevalence of pathogenic fungal infections, coupled with the emergence of new
fungal pathogens, has rapidly brought these diseases to the forefront of global health
problem. Of particular concern are the millions of people worldwide that will contract lifethreating invasive fungal infections (IFI) – diseases with a mortality rate which exceeds
50%, even with the availability of antifungal treatments

91,92.

As a whole, the aetiological

agents responsible for more than 90% of IFI-related deaths fall largely within four genera
of fungi: Cryptococcus, Candida, Aspergillus, and Pneumocytis

91,93.

While antifungal

treatments have advanced over the last decade, patient outcomes have not substantially
improved

94.

These shortcomings are largely attributed to the evolutionary similarity

between fungi and humans, which limits the scope of drug development against fungal
specific targets. As such, there is a pressing need to understand the unique cellular
mechanisms that govern fungal viability. Given that S. cerevisiae is evolutionarily related
to a number of pathogenic fungi, and in particular to the Candida species 95, most genes
from S. cerevisiae are highly conserved in pathogenic fungal strains. Among the shared
genomic features includes similar mechanisms for cell wall homeostasis 96–98 and activation
of stress responses 99. Here we show that hyperactivation of TORC1 signaling sensitizes
yeast cells to both ER stress and cell wall stressors by compromising cell wall integrity.
Therefore, targeting TORC1 signaling and ER stress pathways may be useful in developing
novel targets for antifungal drugs.
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3.1 Discussion, Future Directions and Conclusions
The UPR is a major stress response pathway that is activated in response to an
accumulation of misfolded proteins in the ER1,2. To mediate protein folding homeostasis,
the UPR increases the protein folding capacity and decreases the protein folding load in
the ER. While initially thought to function in isolation during ER stress, recent research
indicates that the UPR is finetuned by signaling pathways from other cellular
compartments. For instance, in S.cereviasie, both the Slt2 cell wall integrity pathway and
the Hog1 hyperosmotic pathway have been implicated in the response to ER stress3–5.
Furthermore, the transcriptional response to ER stress includes the induction of the
general stress response (GSR) which is governed by PKA signaling and regulated by the
Msn2/4 transcription factors6,7. Aside from its role in mediating the GSR, deactivation of
PKA signaling during ER stress also decreases the protein folding load in the ER, namely
by repressing ribosome biogenesis8,9. Given that downregulation of ribosome
biosynthesis is a consequence of ER stress, we rationalized that exploring pathways
involved in ribosomal homeostasis would allow us to elucidate key players that interface
with the UPR to regulate ER homeostasis. Interestingly, in S. cerevisiae, the target of
rapamycin complex 1 (TORC1) signaling pathway couples cell nutrient status and stress
signaling to regulate ribosome biogenesis10,11. As such, elucidating the interplay between
cell growth regulators, such as PKA and TORC1 signaling, and stress response pathways
such as the UPR, is crucial in facilitating an understanding of the cellular response to
proteotoxic stress.
Here we show that attenuating TORC1 signaling is required for adaptation to ER stress;
however, what remains unclear are the upstream pathways responsible for propagating
this signal to TORC1. Attenuation of TORC1 signaling during ER stress may be
regulated by alterations in membrane composition12,13. In this regard, intracellular
signaling pathways could be activated in response to changes in the physical properties of
the plasma membrane such as fluidity or thickness 14. More specifically, the impaired
transport of membrane proteins and lipids from the secretory pathway, during ER stress,
may trigger a signal to repress ribosome biogenesis in order to relieve secretory stress. Of
particular interest are sphingolipids, molecules that not only function as second
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messengers, but are also trafficked through the secretory pathway and delivered as
integral components of the plasma membrane14–16. Recent research has proposed that
sphingolipid/Pkh1/2-TORC1/Sch9 signaling may play a role in the transcriptional
repression of ribosomal proteins, following tunicamycin-induced ER stress17,18.
Nevertheless, further work is required to identify key sensors that impinge on TORC1 to
attenuate downstream signaling during ER stress.
To determine how impacting proper TORC1 signaling affects the cell’s response to ER
stressors, we used a constitutive allele of the TOR1 kinase, TOR1L2134M. We show that
constitutive activation of TORC1 prevents its downregulation and confers increased
sensitivity to ER stressors such as Tm and inositol withdrawal, independently of the
UPR. We propose that TORC1 hyperactivation results in cell wall remodeling and
impaired SWI4/6 signaling, and thereby sensitizes cells to ER stressors and cell wall
antagonists, including the antifungal caspofungin (Fig. 3.1). This observation is
particularly relevant to the field of pathogenic fungal infections, where there is a pressing
need to identify novel targets for antifungal drugs. Interestingly, the components of the
ER stress response pathways have been studied extensively in a number of fungal
pathogens including the Asperigullus species19–21, Cryptoccous neoformans22,23,
Cryptococcus gattii24, Candida albicans25, and Candida galbrata26, with the basic aspects
of the Ire1-mediated response being highly conserved amongst the species. However,
while the ER stress response pathways play a redundant role in the virulence of most
pathogenic species, there are some notable differences between species, particularly in
Candida glabrata, where the Ire1-mediated ER stress response appears to be independent
of HAC1 splicing26,27. Therefore, it would be interesting to assess how these slight
modifications in UPR signaling alter the response to ER stress signaling and whether
hyperactivation of TORC1 signaling also sensitizes these pathogenic fungi to ER stress
and antifungal drugs.
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Figure 3.1: Proposed model of the cellular response to hyperactive of TORC1
Hyperactive TORC1 signaling may compromise cell wall architecture by impairing
Swi4/6 signaling. This disruption in cell wall integrity increases sensitivity to
endoplasmic reticulum stress.
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If hyperactivation of TORC1 signaling does sensitize pathogenic fungi to ER stress,
another future direction of our study would be to design a therapeutic approach for
TORC1 hyperactivation. Interestingly, previous studies in mammalian cells28,
Drosophila29, Schizosaccharomyces pombe30, and Saccharomyces cerevisiae31 have
implicated the Rag family of GTPases, Gtr1 and Gtr2, in the activation of TORC1
signaling. These studies indicate that Vam6, a GTP exchange factor (GEF), colocalizes
with Gtr1 and TORC1 at the vacuole membrane and controls TORC1 by activating
Gtr132–35. Additionally, assessment of nucleotide restricted GTR1 and GTR2 alleles
revealed that GTP-loaded Gtr1 and GDP-loaded Gtr2 stimulate TORC1 and GDP-loaded
Gtr1 has a dominant negative phenotype31. Furthermore, GTP-loaded Gtr1 physically
interacts with the Tco89 subunit of the TORC1 complex, suggesting that Gtr1
specifically controls TORC1 function31. Interestingly, overexpressing Vam6 rendered
wild-type yeast cells resistant to low rapamycin concentrations and suppressed the semidominant growth defect resulting from GDP-loaded Gtr131. Taken together, these results
indicate that overexpressing the Vam6 GEF or inhibiting GTP hydrolysis may both be
mechanisms to hyperactive TORC1 signaling in an antifungal context. Therefore, future
experiments can assess the druggability of Vam6 or Gtr1 and examine them as potential
activators of TORC1 signaling and novel targets for antifungal therapies.
Interestingly, the connection between TORC1 signaling and pathogenic fungal infections
has been characterized through the use of the TORC1 inhibitor, rapamycin. In particular,
rapamycin exerted growth inhibitory activity against Mucor circinelloides – an
opportunistic fungal pathogen that infects patients with diabetes mellitus and solid organ
transplants36. Similarly, other studies demonstrated that rapamycin has potent antifungal
activity against C. albicans and C. neoformans through FKBP12-mediated inhibition of
the Tor1 protein kinase37. As a whole, these observations suggest that TORC1 activation
is required for fungal virulence, and that inhibition of TORC1 activity has potent
antifungal effects. Additionally, our study in budding yeast demonstrated that TORC1
signaling needs to be properly regulated under conditions of cell stress and that inhibition
of TORC1 signaling exacerbates toxicity to canonical ER stressors. Given that
pathogenic fungi are constantly exposed to environmental stressors, exploring how
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inhibition of TORC1 signaling affects cell stress response pathways may be an interesting
avenue of study.
Conversely, recent findings in C. albicans support the model wherein the Tor1 protein
kinase negatively regulates cellular adhesion38. Activation of Tor1 blocks cellular
aggregation by promoting expression of adhesion transcriptional repressors, whereas
inhibition of Tor1 activity, either during nutrient limiting conditions or rapamycin
treatment, leads to expression of adhesion genes and formation of cellular aggregations,
processes that are vital for C. albicans virulence traits such as niche colonization and
biofilm secretion38. Taken together, these findings suggest that hyperactivation may also
be a useful technique to inhibit virulence of pathogenic fungi. In essence, TORC1 activity
may differentially mediate virulence traits in different fungal strains, such that inhibition
of TOR may prove to be more efficacious against some fungal strains, whereas
hyperactivation of TORC1 signaling may prove to have more portent antifungal activity
in other strains. Nevertheless, the regulation of TORC1 signaling is an essential
component of disease propagation, thus further work is required to examine how this
nutrient-sensing pathway acts in parallel with ER stress response pathways to mediate
cellular homeostasis.
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